Furthermore, higher circulating adiponectin at baseline had been suggested as an independent risk factor for the development of new-onset atrial fibrillation [17] and cardiovascular disease (CVD) morbidity [18]. The gene discussed is ADIPOQ; the disease is cardiovascular disorder.